Rising rates and the linkage between HPV and oropharyngeal cancer necessitate multidisciplinary treatment approaches to reduce long-term morbidity. The leaders of our Cancer Prevention and Control program discuss the latest research and treatment strategies for oropharyngeal cancer occurring in conjunction with HPV. The presenters also examine the effects of behavioral and biological risk factors for oncogenic oral HPV persistence as well as HPV vaccination programs in our Adolescent Health Center aimed at minimizing HPV cervical infections.
Related Presenters
Professor of Pediatrics and Environmental Medicine & Public Health
Chief, Division of Adolescent Medicine
Director, Mount Sinai Adolescent Health Center
Professor of Otolaryngology
Director, Head and Neck Oncologic and Microvascular Reconstructive Surgery
Fellowship Vice Chair, Clinical Research
Co-Chief, Division of Head and Neck Oncology
Professor of Medicine (Hematology and Medical Oncology)
Associate Director, Center for Personalized Cancer Therapeutics
Director, Head and Neck Medical Oncology
Co-Leader, Cancer Clinical Investigation Program
Related Videos
